Scarica l'app Stockscreener
108.82
5.43%
-6.25
Veradermics Inc Borsa (MANE) Ultime notizie
JPMorgan Chase reports a passive stake above 5% in Veradermics (MANE). - Stock Titan
Veradermics: The Momentum Is Building, But Know This Before The H2 2026 Readouts (MANE) - Seeking Alpha
Veradermics (NYSE:MANE) Hits New 12-Month HighHere's What Happened - MarketBeat
MANE Stock Jumps As Traders Zero In On Momentum - StocksToTrade
MANE Stock Surges As Traders Target Volatile Breakout - Timothy Sykes
MANE Stock Surges As Traders Target Volatile Breakout - Timothy Sykes
MANE Stock Jumps On High Volume As Bulls Test Breakout - StocksToTrade
MANE Stock Jumps As Traders Pile Into Volatile Breakout - Timothy Sykes
MANE Stock Jumps As Traders Pile Into Volatile Breakout - Timothy Sykes
MANE Stock Pops On Volatile Rally As Traders Pile In - StocksToTrade
Veradermics (NYSE:MANE) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Veradermics (NYSE:MANE) Aktienprognose & Analystenprognosen - Simply Wall Street
Veradermics (NYSE:MANE) Stock Forecast & Analyst Predictions - Simply Wall Street
Veradermics (NYSE:MANE) Stock Jumps 3.4%Time to Buy? - MarketBeat
Veradermics (NYSE:MANE) Stock Falls 8.1%Here's What Happened - MarketBeat
Top Veradermics (MANE) Competitors 2026 - MarketBeat
Veradermics (NYSE:MANE) Trading 6.1% HigherWhat's Next? - MarketBeat
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Veradermics: Buy Before The Catalysts (NYSE:MANE) - Seeking Alpha
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic - Yahoo Finance
Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE) - theglobeandmail.com
Veradermics at Cantor healthcare conference: hair-loss market in focus By Investing.com - Investing.com Canada
Veradermics at Cantor healthcare conference: hair-loss market in focus - Investing.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com Nigeria
Veradermics at citigroup summit: oral hair-loss drug nears key data - investing.com
Wellington Management Group LLP Buys Shares of 68,531 Veradermics, Incorporated $MANE - MarketBeat
Veradermics (MANE) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Seven Fleet Capital Management LP Purchases Shares of 80,000 Veradermics, Incorporated $MANE - MarketBeat
Hollander David Receives 9,650 Shares and 19,300 Derivative Securities from Veradermics on September 1, 2026 - Kalkine Media
Veradermics (MANE) R&D chief receives new stock and option awards - Stock Titan
Veradermics to Present at Upcoming September Investor Conferences - Yahoo Finance
Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally - Yahoo Finance
Is Veradermics (MANE) Still Undervalued After Its 161% Year To Date Run? - Yahoo Finance
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade - Yahoo Finance
Forget GLP-1 Stocks, Baldness Drugs Are Wall Street’s Next Goldmine - Bloomberg.com
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANE - MarketBeat
Why is Veradermics stock sliding today? By Investing.com - Investing.com Canada
Why is Veradermics stock sliding today? By Investing.com - Investing.com Nigeria
Veradermics stock falls following insider share sale By Investing.com - Investing.com Nigeria
Veradermics (NYSE:MANE) Director Sells 750,000 Shares - MarketBeat
Veradermics (MANE) backer exercises $0.00001 per share warrants - Stock Titan
Veradermics (NASDAQ: MANE) insider sells stock in two August trades - Stock Titan
Veradermics (MANE) R&D chief enters insider ranks with no stake - Stock Titan
Veradermics (NYSE:MANE) Stock Price Down 7.9%Here's Why - MarketBeat
Veradermics (MANE) affiliate plans NYSE sale via BofA Securities - Stock Titan
Form 144 | Veradermics(MANE.US) Insider Proposes to Sell 6.37 Million in Common Stocks - Moomoo
Veradermics Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Veradermics CEO Reid Alexander Waldman disposes of common shares worth $7.24 million - Bitget
Veradermics (NYSE:MANE) Insider Timothy August Durso Sells 43,500 Shares - MarketBeat
6.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):